A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.
Clinical trial NCT03751657 · COMPLETED
Trial details
- NCT number
- NCT03751657
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-29
- Primary completion
- 2019-12-16
- Enrollment
- 247
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.